Literature DB >> 16943430

Dynamic regulation of histone modifications in Xenopus oocytes through histone exchange.

M David Stewart1, John Sommerville, Jiemin Wong.   

Abstract

Histone H3 lysine 9 (H3K9) methylation has broad roles in transcriptional repression, gene silencing, maintenance of heterochromatin, and epigenetic inheritance of heterochromatin. Using Xenopus laevis oocytes, we have previously shown that targeting G9a, an H3K9 histone methyltransferase, to chromatin increases H3K9 methylation and consequently represses transcription. Here we report that treatment with trichostatin A induces histone acetylation and is sufficient to activate transcription repressed by G9a, and this activation is accompanied by a reduction in dimethyl H3K9 (H3K9me2). We tested the possibility that the reduction in H3K9me2 was due to the replacement of methylated H3 with unmethylated H3.3. Surprisingly, we found that both free H3 and H3.3 are continually exchanged with chromatin-associated histones. This dynamic exchange of chromatin-associated H3 with free H3/H3.3 was not affected by alterations in transcriptional activity, elongation, acetylation, H3K9 methylation, or DNA replication. In support of this continual histone exchange model, we show that maintenance of H3K9 methylation at a specific site requires the continual presence of an H3K9 histone methyltransferase. Upon dissociation of the methyltransferase, H3K9 methylation decreases. Taken together, our data suggest that chromatin-associated and non-chromatin-associated histones are continually exchanged in the Xenopus oocyte, creating a highly dynamic chromatin environment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16943430      PMCID: PMC1592870          DOI: 10.1128/MCB.00948-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component.

Authors:  Christèle Maison; Delphine Bailly; Antoine H F M Peters; Jean-Pierre Quivy; Danièle Roche; Angela Taddei; Monika Lachner; Thomas Jenuwein; Geneviève Almouzni
Journal:  Nat Genet       Date:  2002-02-19       Impact factor: 38.330

Review 2.  Epigenetic consequences of nucleosome dynamics.

Authors:  Kami Ahmad; Steven Henikoff
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

Review 3.  Histone methylation: dynamic or static?

Authors:  Andrew J Bannister; Robert Schneider; Tony Kouzarides
Journal:  Cell       Date:  2002-06-28       Impact factor: 41.582

4.  The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly.

Authors:  Kami Ahmad; Steven Henikoff
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

5.  Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor.

Authors:  Jiwen Li; Qiushi Lin; Ho-Geun Yoon; Zhi-Qing Huang; Brian D Strahl; C David Allis; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

6.  Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes.

Authors:  Simona Saccani; Gioacchino Natoli
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

7.  A role for nucleosome assembly in both silencing and activation of the Xenopus TR beta A gene by the thyroid hormone receptor.

Authors:  J Wong; Y B Shi; A P Wolffe
Journal:  Genes Dev       Date:  1995-11-01       Impact factor: 11.361

8.  Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

Authors:  Johnathan R Whetstine; Amanda Nottke; Fei Lan; Maite Huarte; Sarit Smolikov; Zhongzhou Chen; Eric Spooner; En Li; Gongyi Zhang; Monica Colaiacovo; Yang Shi
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

9.  JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor.

Authors:  Kenichi Yamane; Charalambos Toumazou; Yu-ichi Tsukada; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

10.  Active genes are tri-methylated at K4 of histone H3.

Authors:  Helena Santos-Rosa; Robert Schneider; Andrew J Bannister; Julia Sherriff; Bradley E Bernstein; N C Tolga Emre; Stuart L Schreiber; Jane Mellor; Tony Kouzarides
Journal:  Nature       Date:  2002-09-11       Impact factor: 49.962

View more
  6 in total

1.  Chromomeres revisited.

Authors:  Herbert C Macgregor
Journal:  Chromosome Res       Date:  2012-12       Impact factor: 5.239

2.  Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.

Authors:  David P Gavin; Cherise Rosen; Kayla Chase; Dennis R Grayson; Nguwah Tun; Rajiv P Sharma
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

3.  Lampbrush chromosomes enable study of cohesin dynamics.

Authors:  Christopher Austin; Natalya Novikova; Vincent Guacci; Michel Bellini
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

4.  Association of modified cytosines and the methylated DNA-binding protein MeCP2 with distinctive structural domains of lampbrush chromatin.

Authors:  Garry T Morgan; Peter Jones; Michel Bellini
Journal:  Chromosome Res       Date:  2012-12       Impact factor: 5.239

5.  AOF1 is a histone H3K4 demethylase possessing demethylase activity-independent repression function.

Authors:  Ze Yang; Jun Jiang; M David Stewart; David M Stewart; Shankang Qi; Kenichi Yamane; Jiwen Li; Yi Zhang; Jiemin Wong
Journal:  Cell Res       Date:  2010-01-26       Impact factor: 25.617

6.  Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.

Authors:  Feng Miao; David D Smith; Lingxiao Zhang; Andrew Min; Wei Feng; Rama Natarajan
Journal:  Diabetes       Date:  2008-09-05       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.